⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7141789 | 1.00 | — | — | |
| SCHEMBL5009996 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL3848539 | 0.74 | — | — | |
| SCHEMBL16555195 | 0.66 | — | — | |
| SCHEMBL19256482 | 0.63 | ALPL (0.30) | — | |
| SCHEMBL27855079 | 0.62 | ADH1B (0.31) | — | |
| SCHEMBL28292234 | 0.62 | ADH1B (0.31) | — | |
| SCHEMBL7141795 | 0.62 | — | — | |
| SCHEMBL7907833 | 0.62 | — | — | |
| SCHEMBL19127083 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6632795-B1 | Treatment of cancer | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-14 | — | — | US | claimed |
| EP-0981358-B1 | DOLASTATIN-15 DERIVATIVES IN COMBINATION WITH TAXANES | BASF AG (DE) | 2003-05-28 | — | — | EP | claimed |
| EP-0871656-B1 | DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | ABBOTT GMBH & CO KG (DE) | 2002-09-25 | — | — | EP | claimed |
| EP-0832104-B1 | DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | ABBOTT GMBH & CO KG (DE) | 2002-09-04 | — | — | EP | claimed |
| EP-1021200-B1 | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS | BASF AG (DE) | 2002-02-06 | — | — | EP | claimed |
| US-6103698-A | USEFUL IN TREATING CANCER IN A MAMMAL; IN COMBINATION WITH PACLITAXEL AND TAXOTERE | BASF AKTIENGESELLSCHAFT (DE) | 2000-08-15 | — | — | US | claimed |
| EP-1021200-A1 | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS | BASF AKTIENGESELLSCHAFT (DE) | 2000-07-26 | — | — | EP | claimed |
| EP-0981358-A1 | DOLASTATIN-15 DERIVATIVES IN COMBINATION WITH TAXANES | BASF AKTIENGESELLSCHAFT (DE) | 2000-03-01 | — | — | EP | claimed |
| US-6015790-A | Methods and compositions for treating rheumatoid arthritis | BASF AKTIENGESELLSCHAFT (DE) | 2000-01-18 | — | — | US | claimed |
| WO-1999017792-A1 | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-15 | — | — | WO | claimed |
| WO-1999017709-A2 | METHODS AND COMPOSITIONS FOR TREATING RHEUMATOID ARTHRITIS | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-15 | — | — | WO | claimed |
| US-5831002-A | HYBRID POLYPEPTIDE | BASF AKTIENGESELLSCHAFT (DE) | 1998-11-03 | — | — | US | claimed |
| EP-0871656-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-10-21 | — | — | EP | claimed |
| WO-1998040092-A1 | DOLASTATIN-15 DERIVATIVES IN COMBINATION WITH TAXANES | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-17 | — | — | WO | claimed |
| EP-0832104-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-01 | — | — | EP | claimed |
| WO-1996040752-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-19 | — | — | WO | claimed |
| WO-1996040751-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-19 | — | — | WO | claimed |
| CN-104981457-B | Heterocyclic compound | 武田药品工业株式会社 | 2017-09-19 | — | — | CN | disclosed |
| WO-1996040751-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040752-A1 | NOVEL DOLASTATIN DERIVATIVES, THEIR PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 1996-12-19 | — | — | WO | disclosed |